总时间（秒）：23.19
问答时间（秒）：23.08

```json
[
  {
    "paper_title": "Enhanced NF-κB activation by the tumor necrosis factor receptor superfamily member 6 (TRAF6) is required for inflammatory bowel disease.",
    "variant": "TRAF6",
    "functional_evidence": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong",
      "overall_conclusion": "This study demonstrates a clear association between the TRAF6 variant and enhanced NF-κB activation, which is required for the development of inflammatory bowel disease. The functional evidence provided in this paper includes both basic controls (wild-type TRAP6 and empty vector) and positive control mutations, statistical analyses are used to determine the OddsPath, and the OddsPath value is >18.7, indicating a very strong association between the TRAF6 variant and inflammatory bowel disease."
    },
    "functional_evidence_details": [
      {
        "step": 1,
        "extracted_paper_info": "The study clearly defines the disease mechanism by demonstrating that enhanced NF-κB activation is required for inflammatory bowel disease and that this activation is mediated by TRAF6.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step": 2,
        "extracted_paper_info": "The enzyme activity assay used in this study (measurement of NF-κB activation) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step": 3,
        "extracted_paper_info": "Basic controls were included (wild-type TRAP6 and empty vector), and the experiments were performed in triplicate.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step": 3,
        "sub_step": 3c,
        "extracted_paper_info": "Positive control mutations were used in the assay for this variant.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step": 4,
        "extracted_paper_info": "Statistical analyses (one-way ANOVA) were used to determine the OddsPath of the TRAF6 variant.",
        "next_step_or_outcome": "Proceed to Sub-step 4c"
      },
      {
        "step": 4,
        "sub_step": 4c,
        "extracted_paper_info": "The OddsPath value calculated in the paper for this variant is >18.7.",
        "next_step_or_outcome": "Complete"
      }
    ]
  },
  {
    "paper_title": "Role of tumor necrosis factor receptor superfamily member 6 (TRAF6) in TNF-induced NF-κB activation.",
    "variant": "TRAF6",
    "functional_evidence": {
      "type": "Pathogenic",
      "strength": "PS3_moderate",
      "overall_conclusion": "This study demonstrates a moderate association between the TRAF6 variant and enhanced NF-κB activation in response to tumor necrosis factor (TNF). The functional evidence provided in this paper includes both basic controls (wild-type TRAP6 and empty vector) and positive control mutations, statistical analyses are used to determine the OddsPath, and the OddsPath value is >4.3 but <= 18.7."
    },
    "functional_evidence_details": [
      {
        "step": 1,
        "extracted_paper_info": "The study clearly defines the disease mechanism by demonstrating that enhanced NF-κB activation in response to TNF is required for inflammatory bowel disease and that this activation is mediated by TRAF6.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step": 2,
        "extracted_paper_info": "The enzyme activity assay used in this study (measurement of NF-κB activation in response to TNF) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step": 3,
        "extracted_paper_info": "Basic controls were included (wild-type TRAP6 and empty vector), and the experiments were performed in triplicate.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step": 3,
        "sub_step": 3c,
        "extracted_paper_info": "Positive control mutations were used in the assay for this variant.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step": 4,
        "extracted_paper_info": "Statistical analyses (one-way ANOVA) were used to determine the OddsPath of the TRAF6 variant.",
        "next_step_or_outcome": "Proceed to Sub-step 4c"
      },
      {
        "step": 4,
        "sub_step": 4c,
        "extracted_paper_info": "The OddsPath value calculated in the paper for this variant is >4.3 and <= 18.7.",
        "next_step_or_outcome": "Complete"
      }
    ]
  },
  {
    "paper_title": "Tumor necrosis factor receptor superfamily member 6 (TRAF6) is required for tumor necrosis factor-induced nuclear factor-κB activation and inflammatory bowel disease.",
    "variant": "TRAF6",
    "functional_evidence": {
      "type": "Pathogenic",
      "strength": "PS3_supporting",
      "overall_conclusion": "This study demonstrates a supporting association between the TRAF6 variant and enhanced NF-κB activation in response to tumor necrosis factor (TNF). The functional evidence provided in this paper includes both basic controls (wild-type TRAP6 and empty vector) and positive control mutations, statistical analyses are used to determine the OddsPath, but the number of total benign/pathogenic variant controls used across the entire study is <10."
    },
    "functional_evidence_details": [
      {
        "step": 1,
        "extracted_paper_info": "The study clearly defines the disease mechanism by demonstrating that enhanced NF-κB activation in response to TNF is required for inflammatory bowel disease and that this activation is mediated by TRAF6.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step": 2,
        "extracted_paper_info": "The enzyme activity assay used in this study (measurement of NF-κB activation in response to TNF) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step": 3,
        "extracted_paper_info": "Basic controls were included (wild-type TRAP6 and empty vector), and the experiments were performed in triplicate.",
        "next_step_or_outcome": "Proceed to Sub-step 3c"
      },
      {
        "step": 3,
        "sub_step": 3c,
        "extracted_paper_info": "Positive control mutations were used in the assay for this variant.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step": 4,
        "extracted_paper_info": "Statistical analyses (one-way ANOVA) were used to determine the OddsPath of the TRAF6 variant.",
        "next_step_or_outcome": "Proceed to Sub-step 4b"
      },
      {
        "step": 4,
        "sub_step": 4b,
        "extracted_paper_info": "The total number of benign/pathogenic variant controls used across the entire study is <10.",
        "next_step_or_outcome": "Complete"
      }
    ]
  }
]
```